Delivery Order SPE2DB22D2009-SPE2DB24FM0TT
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,421.21, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $25,362.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has a Firm Fixed Price (FFP) pricing type and an ultimate completion date of December 18, 2023. This award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award, valued at $33,589.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LOTREL 10-20 MG CAPSULES 100S. The contract has a firm fixed price of $13,284.40 and an ultimate completion date of September 21, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $9,966.33 firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc., doing business as Amerisourcebergen, holds with the DLA Troop Support Medical. This comprehensive IDC enables Amerisourcebergen to efficiently supply a wide range of pharmaceutical products and medical supplies,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,132.72, is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,796.42 firm fixed-price contract is for the supply of LOTREL 10-20 MG CAPSULE 100S, a prescription medication, to support federal healthcare requirements. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite...
This federal contract award, valued at $2,283.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This contract is a delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of LOTREL 10-20 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The $12,395.83 firm-fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 26, 2024 with a completion date of July 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,132.71, is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...